LASCO, Antonino
 Distribuzione geografica
Continente #
EU - Europa 8.878
NA - Nord America 6.874
AS - Asia 4.414
SA - Sud America 1.401
AF - Africa 112
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.693
Nazione #
US - Stati Uniti d'America 6.740
RU - Federazione Russa 4.652
SG - Singapore 1.827
CN - Cina 1.416
BR - Brasile 1.170
IE - Irlanda 1.082
SE - Svezia 949
DE - Germania 564
IT - Italia 478
HK - Hong Kong 439
FR - Francia 321
FI - Finlandia 245
VN - Vietnam 245
GB - Regno Unito 168
UA - Ucraina 136
IN - India 134
PL - Polonia 106
AR - Argentina 80
CA - Canada 69
TR - Turchia 53
BD - Bangladesh 47
EC - Ecuador 44
IQ - Iraq 41
MX - Messico 37
BE - Belgio 34
NL - Olanda 32
VE - Venezuela 30
PK - Pakistan 28
ZA - Sudafrica 23
ES - Italia 22
JP - Giappone 21
MA - Marocco 21
CO - Colombia 20
UZ - Uzbekistan 20
CL - Cile 19
EG - Egitto 15
ID - Indonesia 15
PY - Paraguay 15
AT - Austria 14
CZ - Repubblica Ceca 14
JO - Giordania 14
PH - Filippine 13
SA - Arabia Saudita 13
UY - Uruguay 11
CI - Costa d'Avorio 10
AZ - Azerbaigian 9
DZ - Algeria 9
LT - Lituania 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
CH - Svizzera 8
KE - Kenya 8
NP - Nepal 8
KZ - Kazakistan 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
CU - Cuba 6
DO - Repubblica Dominicana 6
IL - Israele 6
KG - Kirghizistan 6
KR - Corea 6
MY - Malesia 6
PE - Perù 6
TN - Tunisia 5
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
JM - Giamaica 4
RO - Romania 4
BN - Brunei Darussalam 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
IR - Iran 3
LV - Lettonia 3
NG - Nigeria 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
GR - Grecia 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
Totale 21.676
Città #
Moscow 1.256
Dublin 1.080
Ashburn 1.051
Singapore 1.021
Chandler 781
Dallas 690
Nyköping 514
Beijing 499
Hong Kong 413
Jacksonville 373
San Jose 313
Munich 257
The Dalles 241
Princeton 194
Dearborn 189
Los Angeles 156
New York 156
Medford 153
Lauterbourg 148
Messina 147
Ann Arbor 145
Cambridge 133
Bremen 124
Des Moines 118
Boardman 102
Warsaw 92
São Paulo 90
Ho Chi Minh City 85
Helsinki 78
Guangzhou 72
Jinan 67
Tianjin 63
Buffalo 62
Shenyang 57
Turku 54
Hanoi 53
Nanjing 50
San Mateo 48
Frankfurt am Main 46
Wilmington 46
Catania 43
Pune 43
Redondo Beach 43
Orem 40
Lancaster 36
Woodbridge 36
Houston 35
Rio de Janeiro 34
Brussels 33
Seattle 33
Belo Horizonte 30
Curitiba 29
Santa Clara 29
Hebei 28
Zhengzhou 27
Haikou 26
Hangzhou 25
Brasília 24
Council Bluffs 24
Nanchang 24
Brooklyn 23
Chennai 23
Düsseldorf 23
Montreal 23
Nuremberg 21
Taizhou 21
Baghdad 20
Boston 20
Denver 18
Hyderabad 18
Strasbourg 18
Tashkent 18
Johannesburg 17
London 17
Porto Alegre 17
Ningbo 16
Quito 16
Tokyo 16
Chicago 15
Fuzhou 15
Poplar 15
Toronto 15
Amsterdam 14
Jiaxing 14
Rome 13
Taiyuan 13
Goiânia 12
Lahore 12
Manaus 12
Manchester 12
Ankara 11
Atlanta 11
Changsha 11
Istanbul 11
Lanzhou 11
Milan 11
San Francisco 11
Stockholm 11
Abidjan 10
Amman 10
Totale 12.474
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 290
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 235
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 223
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 220
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 217
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 216
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 216
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 215
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 214
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 209
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 206
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 200
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 194
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 187
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 187
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 186
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 186
Hyponatremia as a leading sign of hypopituitarism 184
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 183
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 179
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 178
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 177
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 174
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 171
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 171
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 170
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 170
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 167
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 166
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 165
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 165
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 165
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 164
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 164
Anxiety levels as risk factor for osteoporosis in postmenopausal women 163
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 163
Frailty and lipid profile in elderly hospitalized patients 162
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 161
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 161
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 158
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 158
IL-22 circulating serum levels in centenarians. 157
Healthy centenarians show high levels of circulating interleukin-22 (IL-22). 157
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 157
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 156
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 155
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 155
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 153
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 153
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 153
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 153
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 153
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 152
Sincope conseguente a severa depressione della conduzione atrio-ventricolare trattata con impianto di Pace-maker in un soggetto anziano affetto da fibrillazione atriale permanente e demenza in trattamento con rivastigmina 152
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 151
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 151
Frailty modifications and prognostic impact in older patients admitted in acute care 151
Valutazione e comparazione del filtrato glomerulare stimato con due differenti formule in una popolazione di centenari 148
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 148
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 148
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 148
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 148
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 147
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 146
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 146
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 145
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 145
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 145
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 143
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 143
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 143
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 143
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 143
Relationship between blood pressure and frailty in older hypertensive outpatients 143
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 143
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 141
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 141
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 140
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 140
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 138
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 138
Electrocardiographic changes in centenarians: a study on 42 subjects and comparison with the literature 137
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 137
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 136
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 135
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 135
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 135
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 135
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 135
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 134
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 134
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 132
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 131
DISAPPEARANCE OF A VIRILIZING ADRENAL TUMOR FOLLOWING THERAPY WITH CYPROTERONE ACETATE. 131
Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery 131
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 131
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 130
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 129
Serum levels of apelin-36 are decresed in elderly hospitalized patients with heart failure 128
Totale 16.123
Categoria #
all - tutte 68.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 100 48 45
2021/20221.303 10 183 21 54 33 9 106 39 122 210 127 389
2022/20233.155 225 332 153 206 307 286 21 175 1.314 15 88 33
2023/2024811 62 135 34 107 57 189 19 58 6 27 12 105
2024/20253.519 55 58 61 213 180 111 115 675 898 230 328 595
2025/202610.379 588 845 618 693 899 2.219 1.275 1.471 1.397 374 0 0
Totale 22.018